Nurix Therapeutics, Inc. (NRIX) Reports In-Line Q3 EPS

Go back to Nurix Therapeutics, Inc. (NRIX) Reports In-Line Q3 EPS
(NASDAQ: NRIX) Delayed: 18.65 +1.10 (6.27%)
Previous Close $17.55    52 Week High
Open $17.83    52 Week Low
Day High $18.85    P/E N/A 
Day Low $17.83    EPS
Volume 2,214,257